Who We Are
Prosperdtx is a leader in the emerging field of digital therapeutics proactively delivering targeted support to cancer patients that they may live better lives.
We are at the intersection of medical innovation and computational technology to deliver high-value support while reducing the cost of care.
Who We Are
Prosperdtx is a leader in the emerging field of digital
therapeutics proactively delivering targeted support to cancer patients that they may live better lives.
We are at the intersection of medical innovation and
computational technology to provide high-value support while reducing the cost of care.
What We Do
We are bridging the gaps in the continuity of cancer care through our unique digital health platform by engaging patients and providing personalized care recommendations.
Our Digital Health Platform
Prosperdtx integrates data aggregation, causal-inference machine learning and patient engagement technologies to develop computational phenotypes: personalized patient phenotypes with causal insights that predict disease transitions, therapeutic responses and design personalized care recommendations.
Our Mission
Prosperdtx looks to improve cancer patient outcomes by replacing the current low-value care with personalized and prospective digital care solutions that deliver high-value outcomes to the patient and patient care stakeholders.
Our Leadership
We are creating a new cancer care future by harnessing the power of real-world evidence-based science and working closely with patient, payors, cancer care providers and patient advocacy groups to develop a portfolio of clinically validated digital therapeutics that help cancer patients live better lives and meaningful reduce hospitalizations – the highest costs of cancer care.
